Ticlopidine versus aspirin for stroke prevention: On-treatment results from the ticlopidine aspirin stroke study.

  • Published 1993 in
    Journal of stroke and cerebrovascular diseases…

Abstract

Ticlopidine is the newest antiplatelet agent that has been compared with aspirin for stroke prevention. Results from the intent-to-treat analysis of the Ticlopidine Aspirin Stroke Study, a randomized, triple-blind trial, showed ticlopidine to be more effective than aspirin for the prevention of threatened stroke. We present the on-treatment analysis from… (More)
DOI: 10.1016/S1052-3057(10)80157-0

Topics

  • Presentations referencing similar topics